Bausch & Lomb Eye Drop Patents Survive AIA Review
The Patent Trial and Appeal Board said in final decisions Thursday that a trio of generic drugmakers had failed to show that two Bausch & Lomb Inc. patents on the eye...To view the full article, register now.
Already a subscriber? Click here to view full article